Krsnaa Diagnostics Limited

NSEI:KRSNAA Rapport sur les actions

Capitalisation boursière : ₹23.4b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Krsnaa Diagnostics Croissance future

Future contrôle des critères 5/6

Krsnaa Diagnostics devrait augmenter ses bénéfices et son chiffre d'affaires de 36.9% et de 24.8% par an respectivement. Le BPA devrait croître de de 37% par an. Le rendement des capitaux propres devrait être 14.1% dans 3 ans.

Informations clés

36.9%

Taux de croissance des bénéfices

37.0%

Taux de croissance du BPA

Healthcare croissance des bénéfices26.1%
Taux de croissance des recettes24.8%
Rendement futur des capitaux propres14.1%
Couverture par les analystes

Low

Dernière mise à jour08 Aug 2024

Mises à jour récentes de la croissance future

Krsnaa Diagnostics Limited (NSE:KRSNAA) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Aug 10
Krsnaa Diagnostics Limited (NSE:KRSNAA) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Krsnaa Diagnostics Limited Just Missed Earnings - But Analysts Have Updated Their Models

Feb 16
Krsnaa Diagnostics Limited Just Missed Earnings - But Analysts Have Updated Their Models

Recent updates

Krsnaa Diagnostics (NSE:KRSNAA) Has Announced That Its Dividend Will Be Reduced To ₹2.50

Aug 23
Krsnaa Diagnostics (NSE:KRSNAA) Has Announced That Its Dividend Will Be Reduced To ₹2.50

Krsnaa Diagnostics Limited (NSE:KRSNAA) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Aug 10
Krsnaa Diagnostics Limited (NSE:KRSNAA) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Is Being Reduced To ₹2.50

Aug 09
Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Is Being Reduced To ₹2.50

Krsnaa Diagnostics Limited's (NSE:KRSNAA) 28% Jump Shows Its Popularity With Investors

Jul 05
Krsnaa Diagnostics Limited's (NSE:KRSNAA) 28% Jump Shows Its Popularity With Investors

Here's What To Make Of Krsnaa Diagnostics' (NSE:KRSNAA) Decelerating Rates Of Return

Jun 16
Here's What To Make Of Krsnaa Diagnostics' (NSE:KRSNAA) Decelerating Rates Of Return

We Think That There Are More Issues For Krsnaa Diagnostics (NSE:KRSNAA) Than Just Sluggish Earnings

May 26
We Think That There Are More Issues For Krsnaa Diagnostics (NSE:KRSNAA) Than Just Sluggish Earnings

Is Krsnaa Diagnostics (NSE:KRSNAA) A Risky Investment?

Mar 14
Is Krsnaa Diagnostics (NSE:KRSNAA) A Risky Investment?

Krsnaa Diagnostics Limited Just Missed Earnings - But Analysts Have Updated Their Models

Feb 16
Krsnaa Diagnostics Limited Just Missed Earnings - But Analysts Have Updated Their Models

Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75

Aug 31
Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75

Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75

Aug 17
Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75

Returns On Capital Are Showing Encouraging Signs At Krsnaa Diagnostics (NSE:KRSNAA)

Jun 03
Returns On Capital Are Showing Encouraging Signs At Krsnaa Diagnostics (NSE:KRSNAA)

Revenue Miss: Krsnaa Diagnostics Limited Fell 6.4% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Feb 17
Revenue Miss: Krsnaa Diagnostics Limited Fell 6.4% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Take Care Before Diving Into The Deep End On Krsnaa Diagnostics Limited (NSE:KRSNAA)

Feb 16
Take Care Before Diving Into The Deep End On Krsnaa Diagnostics Limited (NSE:KRSNAA)

Krsnaa Diagnostics' (NSE:KRSNAA) Anemic Earnings Might Be Worse Than You Think

Nov 17
Krsnaa Diagnostics' (NSE:KRSNAA) Anemic Earnings Might Be Worse Than You Think

Prévisions de croissance des bénéfices et des revenus

NSEI:KRSNAA - Estimations futures des analystes et données financières antérieures (INR Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
3/31/202712,6421,7521,000N/A2
3/31/202610,6251,287483N/A3
3/31/20257,633871-69N/A2
6/30/20246,503601N/AN/AN/A
3/31/20246,196568-1,695243N/A
12/31/20235,866570N/AN/AN/A
9/30/20235,464577-677842N/A
6/30/20235,138625N/AN/AN/A
3/31/20234,871621-651763N/A
12/31/20224,621611N/AN/AN/A
9/30/20224,505638-1,125477N/A
6/30/20224,358610N/AN/AN/A
3/31/20224,555684-381,284N/A
12/31/20214,431395N/AN/AN/A
3/31/20213,9651,8493571,026N/A
12/31/20203,6941,307256963N/A
3/31/20202,584-1,120-389378N/A
3/31/20192,092-621-415583N/A
3/31/20181,076-602N/A391N/A
3/31/2017569-39N/A622N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de KRSNAA ( 36.9% par an) est supérieure au taux d'épargne ( 6.7% ).

Bénéfices vs marché: Les bénéfices de KRSNAA ( 36.9% par an) devraient croître plus rapidement que le marché Indian ( 16.9% par an).

Croissance élevée des bénéfices: Les bénéfices de KRSNAA devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de KRSNAA ( 24.8% par an) devrait croître plus rapidement que le marché Indian ( 10% par an).

Croissance élevée des revenus: Le chiffre d'affaires de KRSNAA ( 24.8% par an) devrait croître plus rapidement que 20% par an.


Prévisions de croissance du bénéfice par action


Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de KRSNAA devrait être faible dans 3 ans ( 14.1 %).


Découvrir les entreprises en croissance